Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05305> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05305 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05305 label "Cintredekin Besudotox [drugbank:DB05305]" assertion.
- drugbank:DB05305 seeAlso DB05305 assertion.
- drugbank:DB05305 description "Cintredekin besudotox has been developed as a specific tumor-targeting agent, which is administered by positive-pressure convection-enhanced delivery (CED) directly to brain tissue at risk for residual infiltrating glioblastoma multiforme (GBM) after tumor resection. cintredekin besudotox is made from a human protein, Interleukin 13 (IL13), linked to a bacterial toxin, Pseudomonas exotoxin (PE). The IL13 portion binds to receptors on the tumor." assertion.
- drugbank:DB05305 identifier "drugbank:DB05305" assertion.
- drugbank:DB05305 title "Cintredekin Besudotox" assertion.
- drugbank:DB05305 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05305 drugbank_vocabulary:drugbank-id "DB05305" assertion.
- drugbank:DB05305 bio2rdf_vocabulary:x-identifiers.org DB05305 assertion.
- drugbank:DB05305 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05305" assertion.
- drugbank:DB05305 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05305 bio2rdf_vocabulary:identifier "DB05305" assertion.